Insider Ownership

Name	Relationship / Title	Current Shares	Trading Activity
graziano chane	Officer	3,698,481	View
Date	Type	Shares Traded	Price Range USD
06/04/2010	Acquisition (Non Open Market)	133,600	n/a
Green, David	Officer	1,574,811	View
Date	Type	Shares Traded	Price Range USD
06/04/2010	Acquisition (Non Open Market)	133,600	n/a
03/05/2009	Automatic Buy	453	2.49
03/03/2009	Automatic Buy	687	2.48 - 2.49
03/02/2009	Automatic Buy	2,587	2.49
02/27/2009	Automatic Buy	9,800	2.40 - 2.47
02/26/2009	Automatic Buy	4,789	2.49
02/03/2009	Automatic Buy	100	2.49
02/02/2009	Automatic Buy	722	2.47 - 2.49
01/27/2009	Automatic Buy	2,100	2.45 - 2.49
12/22/2008	Automatic Buy	10,000	2.44 - 2.50
12/19/2008	Automatic Buy	10,000	2.37 - 2.50
12/05/2008	Automatic Buy	100	2.00
12/04/2008	Automatic Buy	10,000	1.97 - 2.00
12/03/2008	Automatic Buy	1,400	2.00
12/02/2008	Automatic Buy	3,200	2.00
12/01/2008	Automatic Buy	10,000	1.98 - 2.00
hso limited partnership	Beneficial Owner (10% or more)	2,757,257	View
Date	Type	Shares Traded	Price Range USD
05/16/2008	Sell	733,300	5.00
11/20/2007	Buy	5,617	3.87
11/19/2007	Buy	5,043	3.74
11/16/2007	Buy	18,299	3.90 - 3.91
11/15/2007	Buy	18,378	3.80 - 3.82
10/01/2007	Buy	6,136	4.43
09/28/2007	Buy	14,254	4.42
09/25/2007	Sell	73	4.52
08/31/2007	Buy	720	4.60
08/27/2007	Buy	3,015	4.68
08/22/2007	Buy	2,565	4.64
08/21/2007	Buy	1,738	4.54
08/20/2007	Buy	7,055	4.53
08/10/2007	Buy	27,948	4.32
08/09/2007	Buy	23,211	4.58
08/08/2007	Buy	15,640	4.78
08/07/2007	Buy	7,808	4.78
08/06/2007	Buy	10,596	4.77
08/03/2007	Buy	5,375	4.93
08/01/2007	Buy	2,578	4.94
07/31/2007	Buy	1,071	4.97
Lewis, Earl R.	Director	70,000	View
Date	Type	Shares Traded	Price Range USD
09/16/2009	Buy	5,534	3.75
09/15/2009	Buy	14,466	3.69 - 3.73
12/02/2008	Buy	15,000	2.00 - 2.10
12/01/2008	Buy	10,000	2.03
12/11/2007	Buy	25,000	4.25 - 4.40
luscinski susan m	Officer	289,250	View
Date	Type	Shares Traded	Price Range USD
06/04/2010	Acquisition (Non Open Market)	66,800	n/a
11/12/2009	Option Execute	98,550	1.05
mcnaughton thomas	Officer	66,800	View
Date	Type	Shares Traded	Price Range USD
06/04/2010	Acquisition (Non Open Market)	66,800	n/a
skystone advisors llc	Beneficial Owner (10% or more)	997,831	View
Date	Type	Shares Traded	Price Range USD
04/01/2009	Disposition (Non Open Market)	2,746,988	n/a
03/26/2009	Sell	5,860	3.00
03/24/2009	Sell	1,300	3.10
03/12/2009	Sell	7,958	2.75
05/16/2008	Sell	1,000,000	5.00
12/31/2007	Buy	4,362	4.51
11/20/2007	Buy	9,177	3.87
11/19/2007	Buy	7,164	3.74
11/16/2007	Buy	24,158	3.90 - 3.91
11/15/2007	Buy	26,935	3.80 - 3.82
10/12/2007	Buy	100	4.69
10/01/2007	Buy	7,796	4.43
09/28/2007	Buy	19,700	4.42
09/25/2007	Sell	100	4.52
09/25/2007	Buy	100	4.50
08/31/2007	Buy	2,617	4.60
08/28/2007	Buy	480	4.53
08/27/2007	Buy	3,400	4.68
08/22/2007	Buy	3,761	4.64
08/21/2007	Buy	3,387	4.54
08/20/2007	Buy	8,542	4.53
08/10/2007	Buy	27,948	4.32
08/09/2007	Buy	50,077	4.58
08/08/2007	Buy	23,225	4.78
08/07/2007	Buy	8,796	4.78
08/06/2007	Buy	17,505	4.77
08/03/2007	Buy	7,200	4.93
08/01/2007	Buy	2,585	4.94
07/31/2007	Buy	2,606	4.97
Uveges, George	Director	10,000	View
Date	Type	Shares Traded	Price Range USD
09/15/2009	Buy	2,500	3.70
11/26/2008	Buy	2,500	1.95 - 1.96
12/12/2007	Buy	1,000	4.21
12/11/2007	Buy	4,000	4.10 - 4.15

Stock transaction information provided by EDGAR Online. Harvard Bioscience, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.